Outset Medical Inc (OM)
2.995
+0.16
(+5.46%)
USD |
NASDAQ |
May 02, 16:00
2.995
0.00 (0.00%)
After-Hours: 20:00
Outset Medical Revenue (Quarterly): 30.51M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 30.51M |
| September 30, 2023 | 30.36M |
| June 30, 2023 | 36.04M |
| March 31, 2023 | 33.47M |
| December 31, 2022 | 32.01M |
| September 30, 2022 | 27.76M |
| June 30, 2022 | 25.06M |
| March 31, 2022 | 30.55M |
| December 31, 2021 | 28.15M |
| Date | Value |
|---|---|
| September 30, 2021 | 26.32M |
| June 30, 2021 | 25.22M |
| March 31, 2021 | 22.92M |
| December 31, 2020 | 17.25M |
| September 30, 2020 | 13.76M |
| June 30, 2020 | 11.74M |
| March 31, 2020 | 7.19M |
| December 31, 2019 | 7.085M |
| September 30, 2019 | 2.63M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
2.63M
Minimum
Sep 2019
36.04M
Maximum
Jun 2023
22.67M
Average
25.77M
Median
Revenue (Quarterly) Benchmarks
| AngioDynamics Inc | 75.18M |
| Baxter International Inc | 3.885B |
| Allurion Technologies Inc | 8.235M |
| Perspective Therapeutics Inc | -5.239M |
| Xtant Medical Holdings Inc | 28.11M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -38.60M |
| Total Expenses (Quarterly) | 67.86M |
| EPS Diluted (Quarterly) | -0.77 |
| Enterprise Value | 70.23M |
| Gross Profit Margin (Quarterly) | 25.28% |
| Profit Margin (Quarterly) | -126.5% |
| Earnings Yield | -116.9% |
| Normalized Earnings Yield | -116.86 |